We propose that epithelial CRC cells deliver miR‐200 to fibroblasts in EVs, attenuating stromal ZEB1 and decreasing sensitivity to TGF‐β‐mediated myofibroblastic differentiation. The gene discussed is ZEB1; the disease is colorectal carcinoma.